Hikma Pharmaceuticals launches pre-filled syringes in US

Writer,

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Generic drugs company Hikma Pharmaceuticals said it had launched a new pre-filled syringe capability in the US.

The first medicine available was is Heparin sodium injection.

;Medical professionals are always in need of tools that help them improve the speed, safety and accuracy of patient care and that is why Hikma is excited to launch our prefilled syringe capability,' commerical and business development head Dan Motto said.

At 9:16am: (LON:HIK) Hikma Pharmaceuticals PLC share price was +35.25p at 1972.25p